Quarterly report · Q2
4937.TEDINET S100TFBP
Period2023-10-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥934m | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥1.7bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥900m | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | −¥87m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥209m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | −¥84m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥288m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥216m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥84m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥216m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥111m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥28m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥211m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥111m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥211m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥3.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.0bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥809m | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥773m | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥954m | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥906m | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥67m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥456m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥365m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥12m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥49m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥9m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥130m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥107m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-33.54 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.16 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.43 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.24 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.62 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.32 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥69.52 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 66.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥75,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥75,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥200m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥712m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥712m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥75,000 |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥154m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥222m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥222m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥42m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥934m |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥934m |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥75,000 |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥113m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥188m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥859m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥860m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥386,000 |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥399m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥41m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥41m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥2m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥900m |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥901m |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥386,000 |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥397m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 432
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人クレア | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)橘内 進 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)塚田 英樹 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 900273000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 934335000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1726314000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 216054000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -84300000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 287722000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 211143000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -110969000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 28360000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 211143000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -110969000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 28360000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 953676000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 2045135000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 772888000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 1631079000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 3084083000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 1581432000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 70.24 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -33.54 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 9.43 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 69.52 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 9.32 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.585 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.662 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.489 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 365385000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -67490000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 455850000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | 8500000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | 11505000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -49057000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -106650000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 130401000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -7991000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 1173460000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 1494500000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1305025000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 47.62 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -0.16 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3618928 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3618928 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 3618928 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 3618928 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |